Table 2.
Plasma phosphorus or iron levels on Day 0 and percentage change (%) of plasma phosphorus or iron levels compared with Day 0
Phosphorus Plasma (phosphorus) (mmol·L−1) | Percentage change versus Day 0 (%) | Iron Plasma (iron) (µmol·L−1) | Percentage change versus Day 0 (%) | |||
---|---|---|---|---|---|---|
Treatment | Day 0 | Day 5 | Day 25 | Day 0 | Day 5 | Day 25 |
Saline | 3.3 ± 0.8 | −5 | −10 | 43.4 ± 15.6 | +12 | −2 |
Gadoterate | 3.0 ± 0.2 | +6 | −1 | 42.1 ± 7.2 | +21 | +18 |
Gadodiamide | 3.1 ± 0.3 | −7 | −13 | 37.1 ± 8.3 | § | § |
Gadobutrol | 2.7 ± 0.4 | −8 | −15 | 43.8 ± 9.5 | +5 | +3 |
Gadobenate | 2.8 ± 0.5 | −13 | −15 | 47.8 ± 9.8 | § | § |
Ca-DOTA | 2.8 ± 0.3 | −8 | −15 | 33.5 ± 6.0 | +18 | +3 |
Ca-DTPA | 2.8 ± 0.2 | −30* | −13 | 37.8 ± 8.6 | § | § |
P < 0.05 versus control (saline) group.
Analytical interference. Uninterpretable data.